Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoosier Cancer Research Network
With
United States Department of Defense
Indiana University
Emory University
OUTLINE: This is a multi-center study.
Sample Collection:
* Tumor sample
* Serum sample
Treatment Regimen:
* All registered patients must be planning treatment with lonafarnib
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
Age \> 18 years.
Planned treatment with lonafarnib for metastatic breast cancer.
Must consent to have a biopsy performed to obtain fresh tissue or be able to identify a formalin fixed paraffin embedded (FFPE) tissue block in which tumor samples can be obtained to complete the testing for this study.
You may not be if
Planned treatment with any other treatment regimen
Clareo Health | Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
